
Monitoring open science: what key practices should we measure?
Discover the results of a consensus study in the biomedical research community.
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Discover the results of a consensus study in the biomedical research community.
What’s standing in the way of researchers adopting good practices on clinical trial data sharing and transparency?
A US court ruling finds reporting of many clinical trials of unapproved drugs in breach of the law. But responses to the ruling are uncertain.
Less than half of trials on clinicaltrials.gov meet the FDAAA results reporting deadline in a study from Ben Goldacre’s EBM DataLab at Oxford University
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.
Google launches a new search tool to facilitate the discoverability of public datasets.
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.
Missed TIPPA 2018? Read our meeting report to get up to speed!